Svensson C, Kaigas M, Goldman S
Department of General Oncology, Stockholm South Hospital, Sweden.
Int J Colorectal Dis. 1992 Sep;7(3):122-4. doi: 10.1007/BF00360350.
During the last decade conservative treatment of anal carcinoma based on radiotherapy has gained popularity. Radiotherapy is often combined with concurrent chemotherapy although no firm evidence exists that such combinations are more effective than radiotherapy alone. Treatment results with respect to anal sphincter function are generally better for small tumors. In an effort to improve the treatment results for locally advanced epidermoid anal carcinoma, a selection of patients with such tumors has been treated with induction chemotherapy comprising two or three courses of a combination of carboplatin 300-350 mg/m2 i.v. and 5-fluorouracil 1,000 mg/(m2 x d) x 5 d prior to radiotherapy. Six female patients aged 37 to 74 have completed the regimen. All had complete tumor regressions at conclusion of radiotherapy. No recurrence has yet occurred but the follow-up period is still short (8-21 months). No interruption of chemotherapy due to toxic side effects was necessary and no severe toxicity registered. Further study is needed to evaluate the efficacy and toxicity of the regimen, but these early findings are promising.
在过去十年中,基于放疗的肛管癌保守治疗越来越受欢迎。放疗通常与同步化疗联合使用,尽管尚无确凿证据表明这种联合治疗比单纯放疗更有效。对于小肿瘤,肛门括约肌功能方面的治疗效果通常更好。为了提高局部晚期表皮样肛管癌的治疗效果,选择了一些患有此类肿瘤的患者,在放疗前接受包含两到三个疗程的诱导化疗,化疗方案为静脉注射卡铂300 - 350 mg/m² 以及5 - 氟尿嘧啶1000 mg/(m²×d)×5 d。6名年龄在37至74岁之间的女性患者完成了该治疗方案。放疗结束时所有患者肿瘤均完全消退。目前尚未出现复发,但随访期仍较短(8 - 21个月)。无需因毒性副作用而中断化疗,也未记录到严重毒性反应。需要进一步研究来评估该治疗方案的疗效和毒性,但这些早期结果很有前景。